Cellectar Biosciences, Inc.CLRBNASDAQ
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank100
Studio
Year-over-Year Change

Year-over-year net income growth rate

Latest
51.12%
↑ 330% vs avg
Percentile
P100
Near historical high
Streak
2 yr
Consecutive growthAccelerating
Average
-22.23%
Historical baseline
PeriodValue
202551.12%
2024-4.23%
2023-34.53%
2022-31.80%
2021-59.81%
2020-7.10%
2019-6.45%
20182.38%
2017-119.44%
2016-12.47%